The purpose of the “Micronuclei and Disease” special issue (SI) is to: (i) Determine the level of evidence for association of micronuclei (MN), a biomarker of numerical and structural chromosomal aberrations, with risk of specific diseases in humans; (ii) Define plausible mechanisms that explain association of MN with each disease; (iii) Identify knowledge gaps and research needed to translate MN assays into clinical practice.

“Micronuclei and Disease” special issue: Aims, scope, and synthesis of outcomes

Mariagrazia Andreassi;
2021

Abstract

The purpose of the “Micronuclei and Disease” special issue (SI) is to: (i) Determine the level of evidence for association of micronuclei (MN), a biomarker of numerical and structural chromosomal aberrations, with risk of specific diseases in humans; (ii) Define plausible mechanisms that explain association of MN with each disease; (iii) Identify knowledge gaps and research needed to translate MN assays into clinical practice.
2021
Istituto di Fisiologia Clinica - IFC
Micronuclei Disease Cancer Cardiovascular disease Inflammation Ageing
File in questo prodotto:
File Dimensione Formato  
Fenech et al. 2021.pdf

accesso aperto

Descrizione: “Micronuclei and Disease” special issue: Aims, scope, and synthesis of outcomes
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.82 MB
Formato Adobe PDF
1.82 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/530657
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 42
social impact